Group One Trading
IMUX icon

Group One Trading’s Immunic IMUX Stock Holding History

Group One Trading’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23K Sell
145
-25
-15% -$308 ﹤0.01% 7014
2026
Q1 		$1.89K Buy
+170
New +$1.52K ﹤0.01% 7071
2025
Q3 		– Sell
-7,590
Closed -$66.9K – 8724
2025
Q2 		$52.9K Buy
7,590
+1,405
+23% +$12.9K ﹤0.01% 5529
2025
Q1 		$67.4K Sell
6,185
-1,206
-16% -$13K ﹤0.01% 4920
2024
Q4 		$73.9K Buy
+7,391
New +$93.1K ﹤0.01% 4769
2024
Q3 		– Sell
-4
Closed -$57 – 6949
2024
Q2 		$47 Hold
4
– – ﹤0.01% 6574
2024
Q1 		$55 Buy
+4
New +$52 ﹤0.01% 6861
2023
Q4 		– Sell
-43
Closed -$527 – 7753
2023
Q3 		$629 Sell
43
-42
-49% -$807 ﹤0.01% 7301
2023
Q2 		$2.12K Sell
85
-1,007
-92% -$16.9K ﹤0.01% 7073
2023
Q1 		$16.3K Sell
1,092
-5,355
-83% -$99.4K ﹤0.01% 5645
2022
Q4 		$90.3K Buy
6,447
+4,272
+196% +$117K ﹤0.01% 4515
2022
Q3 		$69K Buy
2,175
+2,134
+5,205% +$89.3K ﹤0.01% 5128
2022
Q2 		$1K Sell
41
-1,755
-98% -$112K ﹤0.01% 7556
2022
Q1 		$203K Buy
1,796
+1,076
+149% +$125K ﹤0.01% 4781
2021
Q4 		$69K Buy
720
+578
+407% +$52.1K ﹤0.01% 6059
2021
Q3 		$13K Buy
+142
New +$14K ﹤0.01% 7385
2020
Q4 		– Sell
-54
Closed -$9.7K – 6713
2020
Q3 		$10K Buy
54
+50
+1,250% +$8.19K ﹤0.01% 5425
2020
Q2 		$0 Hold
4
– – ﹤0.01% 5961
2020
Q1 		$0 Hold
4
– – ﹤0.01% 5485
2019
Q4 		$0 Hold
4
– – ﹤0.01% 5326
2019
Q3 		$0 Buy
+4
New +$535 ﹤0.01% 5323
2019
Q2 		– Sell
-405
Closed -$53.2K – 5141
2019
Q1 		$32K Sell
405
-122
-23% -$10.7K ﹤0.01% 3809
2018
Q4 		$39K Buy
527
+425
+417% +$49.8K ﹤0.01% 3674
2018
Q3 		$11K Buy
+102
New +$266K ﹤0.01% 4620
2018
Q2 		– Sell
-3
Closed -$6.93K – 5271
2018
Q1 		$7K Sell
3
-2
-40% -$4.59K ﹤0.01% 4415
2017
Q4 		$12K Hold
5
– – ﹤0.01% 4323
2017
Q3 		$10K Buy
+5
New +$6.52K ﹤0.01% 4290
2015
Q2 		– Sell
-4
Closed -$38.2K – 4987
2015
Q1 		$37K Buy
+4
New +$36.8K ﹤0.01% 3533

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Group One Trading's IMUX Position: Q2 2026 in Review

Group One Trading reduced its Immunic (IMUX) stake by 15% in Q2 2026, selling an estimated $308 and leaving 145 shares worth $2.23K. The position accounts for ﹤0.01% of the portfolio, ranked #7014.

Group One Trading first reported a position in IMUX in Q1 2015 and has held it in 28 quarters since. The position peaked at $203K in Q1 2022. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Group One Trading held 145 shares of Immunic worth $2.23K as of Q2 2026.
  • Group One Trading sold 25 Immunic shares in Q2 2026, an estimated $308.
  • Immunic made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7014 holding.
  • Group One Trading first reported a position in Immunic in Q1 2015 and has held it in 28 quarters since.
  • Group One Trading's Immunic position peaked at $203K in Q1 2022.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.